Karlen Gazarian

Dr. Karlen Gazarian


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2020 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
MHMercedes Azucena Hernandez-Sapiens
Mercedes Azucena Hernandez-Sapiens
EREdwin E. Reza-Zaldívar
Edwin E. Reza-Zaldívar
RCRicardo R. Cevallos
Ricardo R. Cevallos
AMAna L. Márquez-Aguirre
Ana L. Márquez-Aguirre
KGKarlen Gazarian
Karlen Gazarian
Alejandro CanalesAlejandro Canales
Alejandro Canales
Alzheimer’s disease (AD) is a chronic brain disorder characterized by progressive intellectual decline and memory and neuronal loss, caused mainly by extracellular deposition of amyloid-β (Aβ) and intracellular accumulation of hyperphosphorylated tau protein, primarily in areas implicated in memory and learning as prefrontal cortex and hippocampus. There are two forms of AD, a late-onset form that affects people over 65 years old, and the early-onset form, which is hereditable and affect people at early ages ~45 years. To date, there is no cure for the disease; consequently, it is essential to develop new tools for the study of processes implicated in the disease. Currently, in vitro AD three-dimensional (3D) models using induced pluripotent stem cells (iPSC)-derived neurons have broadened the horizon for in vitro disease modeling and gained interest for mechanistic studies and preclinical drug discovery due to their potential advantages in providing a better physiologically relevant information and more predictive data for in vivo tests. Therefore, this study aimed to establish a 3D cell culture model of AD in vitro using iPSCs carrying the A246E mutation. We generated human iPSCs from fibroblasts from a patient with AD harboring the A246E mutation in the PSEN1 gene. Cell reprogramming was performed using lentiviral vectors with Yamanaka’s factors (OSKM: Oct4, Sox2, Klf4, and c-Myc). The resulting iPSCs expressed pluripotency genes (such as Nanog and Oct4), alkaline phosphatase activity, and pluripotency stem cell marker expression, such as OCT4, SOX2, TRA-1-60, and SSEA4. iPSCs exhibited the ability to differentiate into neuronal lineage in a 3D environment through dual SMAD inhibition as confirmed by Nestin, MAP2, and Tuj1 neural marker expression. These iPSC-derived neurons harbored Aβ oligomers confirmed by Western Blot (WB) and immunostaining. With human iPSC-derived neurons able to produce Aβ oligomers, we established a novel human hydrogel-based 3D cell culture model that recapitulates Aβ aggregation without the need for mutation induction or synthetic Aβ exposure. This model will allow the study of processes implicated in disease spread throughout the brain, the screening of molecules or compounds with therapeutic potential, and the development of personalized therapeutic strategies.

26 January 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KGKarlen Gazarian
Karlen Gazarian
LRLuis R Ramírez-García
Luis R Ramírez-García
Human dental tissues are sources of neural crest origin multipotent stem cells whose regenerative potential is a focus of extensive studies. Rational programming of clinical applications requires a more detailed knowledge of the characters inherited from neural crest. Investigation of neural crest cells generated from human pluripotent stem cells provided opportunity for their comparison with the postnatal dental cells. The purpose of this study was to investigate the role of the culture conditions in the expression by dental cells of neural crest characters. The results of the study demonstrate that specific neural crest cells requirements, serum-free, active WNT signaling and inactive SMAD 2/3, are needed for the activity of the neural crest characters in dental cells. Specifically, the decreasing concentration of fetal bovine serum (FBS) from regularly used for dental cells 10% to 2% and below, or using serum-free medium, led to emergence of a subset of epithelial-like cells expressing the two key neural crest markers, p75 and HNK-1. Further, the serum-free medium supplemented with neural crest signaling requirements (WNT inducer BIO and TGF-β inhibitor REPSOX), induced epithelial-like phenotype, upregulated the p75, Sox10 and E-Cadherin and downregulated the mesenchymal genes (SNAIL1, ZEB1, TWIST). An expansion medium containing 2% FBS allowed to obtain an epithelial/mesenchymal SHED population showing high proliferation, clonogenic, multi-lineage differentiation capacities. Future experiments will be required to determine the effects of these features on regenerative potential of this novel SHED population.

1 December 2012 in Peptides
Verified
Journal Article
Closed access
KGKarlen Gazarian
Karlen Gazarian
MRMerril Rowlay
Merril Rowlay
TGTatiana Gazarian
Tatiana Gazarian
JBJorge Enrique Vazquez Buchelli
Jorge Enrique Vazquez Buchelli
MGMarisela Hernández Gonzáles
Marisela Hernández Gonzáles

1 June 2013 in Molecular Immunology
Verified
Journal Article
Closed access
KGKarlen Gazarian
Karlen Gazarian
YPYadira Palacios-Rodríguez
Yadira Palacios-Rodríguez
TGTatiana G. Gazarian
Tatiana G. Gazarian
LHLEONOR HUERTA
LEONOR HUERTA

1 February 2018 in Stem Cells
Verified
Journal Article
Closed access
PDF file
RCRicardo Raúl Cevallos
Ricardo Raúl Cevallos
GRGriselda Rodríguez-Martínez
Griselda Rodríguez-Martínez
KGKarlen Gazarian
Karlen Gazarian

8 February 2017 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
LRL. Ramírez‐García
L. Ramírez‐García
RCR. Cevallos
R. Cevallos
KGKarlen Gazarian
Karlen Gazarian